Why pharma is still far from a treatment for galactosemia
Nearly three months after an experimental treatment for classic galactosemia was rejected by the US Food and Drug Administration (FDA),…
All articles by Robert Barrie
Robert Barrie
Robert Barrie is a news and features reporter for Pharmaceutical Technology and Medical Device Network. Robert holds a BSc in Neuroscience and holds interests in neurological devices, infectious diseases, and company investment such as initial public offerings (IPOs). Contact Rob
-
-
Novo Nordisk plans new study for CagriSema, targets 2026 submission
Novo Nordisk is planning a new Phase III trial for CagriSema, the company’s next-generation obesity drug touted as a potential…
-
Glucotrack hits trial success for direct blood measuring CGM
Glucotrack has successfully completed a first-in-human study with its continuous glucose monitor (CGM) that directly measures glucose levels from a…
-
WHO’s Neglected Tropical Disease Day at unfamiliar odds with US stance
The World Health Organization (WHO) has called for country commitment to combat neglected tropical diseases, as the agency braces itself…
-
Allurion shares soar 77% after sharing plans for GLP-1RA combo trial
If you can’t beat them then join them. In a bid to combat weakening financial performance, Allurion has revealed plans…
-
Atara’s T cell programmes hit with clinical hold after third-party site woes
Atara Therapeutics’ pipeline has hit another obstacle after the US Food and Drug Administration (FDA) halted clinical trials evaluating two…
-
Pulse Biosciences touts positive results from PFA early feasibility study
Pulse Biosciences has reported positive results from a first-in-human feasibility study evaluating its nanosecond pulsed field ablation (nsPFA) technology for…
-
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial
South African biotech Afrigen Biologics has secured a $6.2m grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop…
-
WHO reports eight deaths from suspected Marburg outbreak in Tanzania
Eight people have likely died from an outbreak of Marburg virus disease (MVD) in a northwestern region of Tanzania, according…
-
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic
In moves that continue to strengthen its affiliation with the healthcare industry, NVIDIA has added three new companies to its…